Business
Hinge Health announces $250 million share repurchase program
SAN FRANCISCO, November 12, 2025--Hinge Health, Inc. (NYSE: HNGE) today announced that its board of directors has authorized a $250 million share repurchase program.
About this update from Hinge Health, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":340,"height":200,"url":"https://media.zenfs.com/en/business-wire.com/d9e6558ce7241fbc98a7b8185010f403"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/SfmmQHnPnbT6BAgzyOQ_hg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTM3NjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/d9e6558ce7241fbc98a7b8185010f403","width":340,"height":200}},"lazy":false},{"type":"text","content":"SAN FRANCISCO, November 12, 2025--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced that its board of directors has authorized a $250 million share repurchase program.","length":182,"tagName":"p"},{"type":"text","content":""During the first three quarters of 2025, we generated $108 million in cash from operations and $118 million in free cash flow1, reflecting the strength and scalability of our business model," said James Budge, CFO, Hinge Health. "We maintain a robust balance sheet, with nearly $500 million in cash and investments as of the end of Q3 2025. Notably, substantially all of our IPO proceeds were used towards tax obligations for employee RSU settlement and a small secondary for pre-IPO investors. None was put to our balance sheet for long-term use."","length":569,"tagName":"p"},{"type":"text","content":""Our strong free cash flow puts us in a unique position to be able to invest in organic growth while concurrently evaluating targeted M&A and returning capital to our shareholders," said Daniel Perez, Co-Founder and CEO, Hinge Health. "We expect to continue to invest in improving member outcomes and experiences, while increasing enrollment and reducing costs for our clients. We will also opportunistically repurchase shares to offset future dilution."","length":478,"tagName":"p"},{"type":"text","content":"Share Repurchase Program","length":24,"tagName":"p"},{"type":"text","content":"On November 10, 2025, our board of directors approved a share repurchase program with authorization to purchase up to $250 million of our outstanding Class A Common Stock.","length":171,"tagName":"p"},{"type":"text","content":"Repurchases under the program may be made in the open market, in privately negotiated transactions, or by other methods with the amount and timing of repurchases...